Nancy A. Grygiel - Net Worth and Insider Trading

Nancy A. Grygiel Net Worth

The estimated net worth of Nancy A. Grygiel is at least $3 Million dollars as of 2023-06-10. Nancy A. Grygiel is the SVP & CCO of Amgen Inc and owns about 13,104 shares of Amgen Inc (AMGN) stock worth over $3 Million. Details can be seen in Nancy A. Grygiel's Latest Holdings Summary section.

Transaction Summary of Nancy A. Grygiel

To

Nancy A. Grygiel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nancy A. Grygiel owns 1 companies in total, including Amgen Inc (AMGN) .

Click here to see the complete history of Nancy A. Grygiel’s form 4 insider trades.

Insider Ownership Summary of Nancy A. Grygiel

Ticker Comapny Transaction Date Type of Owner
AMGN Amgen Inc 2020-06-24 SVP & CCO

Nancy A. Grygiel Latest Holdings Summary

Nancy A. Grygiel currently owns a total of 1 stock. Nancy A. Grygiel owns 13,104 shares of Amgen Inc (AMGN) as of November 8, 2022, with a value of $3 Million.

Latest Holdings of Nancy A. Grygiel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AMGN Amgen Inc 2022-11-08 13,104 218.76 2,866,631

Holding Weightings of Nancy A. Grygiel


Nancy A. Grygiel Form 4 Trading Tracker

According to the SEC Form 4 filings, Nancy A. Grygiel has made a total of 2 transactions in Amgen Inc (AMGN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Amgen Inc is the sale of 545 shares on November 8, 2022, which brought Nancy A. Grygiel around $159,979.

Insider Trading History of Nancy A. Grygiel

Ticker
Company
Date
Buy/Sell
Insider Trading Shares
Shares Change
Price
Cost
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
AMGN
Amgen Inc
2021-05-11
Sell
2,500.00
-16.61%
$252.51
$631,275.00
12,551.68
$218.76
-13.37%
-
Total 1
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nancy A. Grygiel Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Nancy A. Grygiel Ownership Network

Ownership Network List of Nancy A. Grygiel

No Data

Ownership Network Relation of Nancy A. Grygiel


Nancy A. Grygiel Owned Company Details

What does Amgen Inc do?

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amjevita (biosimilar Humira).

Who are the key executives at Amgen Inc?

Nancy A. Grygiel is the SVP & CCO of Amgen Inc. Other key executives at Amgen Inc include SVP & Human Resources Derek Miller , SVP & Business Development Rachna Khosla , and VP & Finance & CAO Linda H. Louie .

Amgen Inc (AMGN) Insider Trades Summary

Over the past 18 months, Nancy A. Grygiel made 1 insider transaction in Amgen Inc (AMGN) with a net sale of 545. Other recent insider transactions involving Amgen Inc (AMGN) include a net sale of 800 shares made by R Sanders Williams , a net sale of 13,500 shares made by Jonathan P Graham , and a net sale of 6,600 shares made by Robert Eckert .

In summary, during the past 3 months, insiders sold 0 shares of Amgen Inc (AMGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 21,832 shares of Amgen Inc (AMGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 21,832 shares.

Amgen Inc (AMGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Amgen Inc Insider Transactions

No Available Data

Nancy A. Grygiel Mailing Address

Above is the net worth, insider trading, and ownership report for Nancy A. Grygiel. You might contact Nancy A. Grygiel via mailing address: One Amgen Center Drive, Thousand Oaks Ca 91320.